Predictive biomarkers in PD-1/PD-L1 checkpoint blockade immunotherapy - ScienceDirect
Immune checkpoint blockade in HIV - eBioMedicine
Cancers | Free Full-Text | Immunotherapy Predictive Molecular Markers in Advanced Gastroesophageal Cancer: MSI and Beyond
Long-term persistence and functionality of adoptively transferred antigen-specific T cells with genetically ablated PD-1 expression | PNAS
Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion | Nature Communications
Expression of tumor cell markers and PD-L1 on primary patient-derived cells - Oncolines B.V.
Frontiers | The Role of PD-1 in Acute and Chronic Infection
Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors | Molecular Cancer | Full Text
PD-1-stimulated T cell subsets are transcriptionally and functionally distinct - ScienceDirect
Mechanistic insight of predictive biomarkers for antitumor PD‑1/PD‑L1 blockade: A paradigm shift towards immunome evaluation (Review)
JCM | Free Full-Text | The Evolving Landscape of Biomarkers for Anti-PD-1 or Anti-PD-L1 Therapy
PD-1 Is a Selective Marker of Human Follicular T Cells (A)... | Download Scientific Diagram
The diverse functions of the PD1 inhibitory pathway | Nature Reviews Immunology
PD-L1 - Wikipedia
Tumor cell-intrinsic PD-1 receptor is a tumor suppressor and mediates resistance to PD-1 blockade therapy | PNAS
Frontiers | PD-L1 Distribution and Perspective for Cancer Immunotherapy—Blockade, Knockdown, or Inhibition
PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity
Coexpression of PD-1, NFB activation, and proliferation marker in... | Download Scientific Diagram
Mechanistic insight of predictive biomarkers for antitumor PD‑1/PD‑L1 blockade: A paradigm shift towards immunome evaluation (Review)
Frontiers | Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors
Biomarkers of response to PD-1 pathway blockade | British Journal of Cancer
